Trial Profile
Clinical trials of plazomicin in patients with serious Gram-negative bacterial infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 May 2012
Price :
$35
*
At a glance
- Drugs Plazomicin (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- 16 May 2012 New trial record